TY - JOUR T1 - Retinoid X Receptor α Regulates the Expression of Glutathione <em>S</em>-transferase Genes and Modulates Acetaminophen-Glutathione Conjugation in Mouse Liver JF - Molecular Pharmacology JO - Mol Pharmacol SP - 1590 LP - 1596 DO - 10.1124/mol.105.013680 VL - 68 IS - 6 AU - Guoli Dai AU - Nathan Chou AU - Lin He AU - Maxwell A. Gyamfi AU - Alphonse J. Mendy AU - Angela L. Slitt AU - Curtis D. Klaassen AU - Yu-Jui Y. Wan Y1 - 2005/12/01 UR - http://molpharm.aspetjournals.org/content/68/6/1590.abstract N2 - Nuclear receptors, including constitutive androstane receptor, pregnane X receptor, and retinoid X receptor (RXR), modulate acetaminophen (APAP)-induced hepatotoxicity by regulating the expression of phase I cytochrome P450 (P450) genes. It has not been fully resolved, however, whether they regulate APAP detoxification at the phase II level. The aim of the current study was to evaluate the role of RXRα in phase II enzyme-mediated detoxification of APAP. Wild-type and hepatocyte-specific RXRα knockout mice were treated with a toxic dose of APAP (500 mg/kg i.p.). Mutant mice were protected from APAP-induced hepatotoxicity, even though basal liver glutathione (GSH) levels were significantly lower in mutant mice compared with those of wild-type mice. High-performance liquid chromatography analysis of APAP metabolites revealed significantly greater levels of APAP-GSH conjugates in livers and bile of mutant mice compared with those of wild-type mice. Furthermore, hepatocyte RXRα deficiency altered the gene expression profile of the glutathione S-transferase (Gst) family. Basal expression of 13 of 15 Gst genes studied was altered in hepatocyte-specific RXRα-deficient mice. This probably led to enhanced APAP-GSH conjugation and reduced accumulation of N-acetyl-p-benzoquinone imine, a toxic electrophile that is produced by biotransformation of APAP by phase I P450 enzymes. In conclusion, the data presented in this study define an RXRα-Gst regulatory network that controls APAP-GSH conjugation. This report reveals a potential novel strategy to enhance the detoxification of APAP or other xenobiotics by manipulating Gst activity through RXRα-mediated pathways. ER -